Quick answer: A man's checkup should be based on symptoms, medical and family history, smoking, blood pressure, prior results, medicines, and current screening eligibility—not on an automatic imaging bundle for each decade. Start with established preventive care. Add PSA, colonoscopy, low-dose lung CT, CAC, CCTA, ultrasound, MRI, or DEXA only when the person's risk and a defined clinical question support the test.
This guide is general education for asymptomatic adults. It does not diagnose disease or replace an individual assessment. New symptoms—including chest pain, sudden weakness, severe shortness of breath, black or bloody stool, or difficulty urinating—need timely clinical evaluation rather than a routine screening package.
What usually comes first
The conservative starting point is a review of personal and family history, medicines, smoking and alcohol exposure, blood pressure, weight and waist measurements, and age-appropriate laboratory and cancer screening. Taiwan's current adult preventive service includes a questionnaire, physical measurements, kidney function, glucose, lipids, liver enzymes, uric acid, urine protein, and health counselling for eligible adults.
| Question |
Conservative approach |
| General health |
Begin with history, examination, blood pressure and selected laboratory tests. The interval depends on age, risk and previous results. |
| Colorectal cancer |
Use an accepted screening strategy. Taiwan currently offers FIT every two years for people aged 45 to under 75, and for people aged 40–44 with a family history. An abnormal FIT needs diagnostic follow-up; colonoscopy may also be selected for screening or diagnosis after an individual discussion. |
| Lung cancer |
Low-dose CT is not a general checkup for every man over 40. Use the current age, smoking and family-history criteria. |
| Cardiovascular risk |
Assess standard risk factors first. ECG, carotid ultrasound, CAC or CCTA should not be added automatically because of age. |
| Prostate |
PSA screening involves possible benefit and possible harms such as false-positive results, biopsy and overdiagnosis. It should follow shared decision-making. Prostate ultrasound or MRI is not an automatic companion to PSA screening. |
| Bone health |
Consider fracture risks, medicines and relevant conditions. Evidence is currently insufficient to recommend population DEXA screening for all men solely by age. |
Tests that need a specific reason
ECG and cardiovascular imaging
A resting ECG records the heart's electrical activity, but it does not rule out coronary artery disease. USPSTF recommends against ECG screening to prevent cardiovascular events in asymptomatic, low-risk adults; evidence is insufficient for asymptomatic adults at higher risk. CAC can refine risk for selected people when a treatment decision remains uncertain. CCTA uses radiation and iodinated contrast and should answer a defined clinical question.
Carotid ultrasound, brain MRA and full-body MRI
USPSTF recommends against screening the general asymptomatic adult population for carotid artery stenosis. Brain MRA may be appropriate for selected symptoms, conditions or family histories, but it is not a routine dementia or aneurysm screen for every man over 60. ACR states that evidence is insufficient to recommend total-body MRI for asymptomatic people without risk factors, symptoms or family history. Incidental findings may lead to more tests and anxiety.
PSA and prostate imaging
Under the current USPSTF recommendation, men aged 55–69 should make an individual decision about periodic PSA screening after discussing benefits and harms with a clinician. The recommendation is being updated, so the current version should be checked at the time of care. An elevated PSA is not a cancer diagnosis, and a normal PSA cannot guarantee that cancer is absent. Imaging is selected after clinical assessment; it is not a universal screening pair.
Abdominal ultrasound, liver imaging and tumour markers
Abdominal ultrasound may answer a focused question, but it cannot reliably evaluate every abdominal organ or exclude every cancer. People with chronic hepatitis or another established liver-cancer risk need a clinician-directed surveillance plan. Tumour-marker blood tests generally do not have adequate sensitivity and specificity to function as a broad cancer screen in asymptomatic people.
Testosterone, vitamins and sleep testing
Testosterone testing is usually guided by compatible symptoms and clinical assessment, with confirmation when appropriate; it is not a universal age-based panel. Vitamin testing should be selected for a reason such as diet, symptoms, medicines or a relevant condition. Sleep testing is appropriate when symptoms or risk suggest a sleep disorder, not as a default component of every package.
How to compare a package safely
- Confirm the exact tests and body regions included. Similar package names do not guarantee identical protocols.
- Ask whether contrast, sedation, biopsy, pathology, DICOM files, translated reports and follow-up are included or separately charged.
- Confirm the facility, available dates, equipment, interpreting specialist and report-delivery process in writing.
- Do not stop, start or change medicines based on a web article. Follow the treating clinician's and facility's instructions.
- Choose a test only if you understand what a normal, abnormal or incidental result could lead to next.
Price range and scope
This article records a USD $1,500–$3,500 range for premium men's screening packages in Taipei. It is a package range, not a promise that every examination described above is included. The total changes with the facility, package, imaging regions, contrast, sedation, pathology, translation and follow-up. Check the live New Dawn catalogue and written quotation for the current price, inclusions, exclusions, currency and cancellation terms. If either differs from this article, the live quotation controls.
Sources and limits
Operational note: Facility-specific protocols, equipment, staffing, report language, delivery time, availability and package inclusions require current written confirmation from the provider. They are not established by the medical sources above.